Zhengnan Ming

Xiangya Stomatological Hospital And Xiangya School Of Stomatology/Hunan Key Laboratory Of Oral Health Research
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice

Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: April 25, 2026

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

Journal: Acta biochimica et biophysica Sinica

Published: May 31, 2025

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

Journal: Hepatology communications

Published: February 07, 2025

Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.

Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.

Journal: Journal of natural products

Published: September 08, 2023

ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis.

ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis.

Journal: Cell death & disease

Published: August 02, 2023

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.

Journal: Cancers

Published: March 17, 2023

PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance.

PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance.

Journal: Acta biochimica et biophysica Sinica

Published: January 03, 2021

ARG1 functions as a tumor suppressor in breast cancer.

ARG1 functions as a tumor suppressor in breast cancer.

Journal: Acta biochimica et biophysica Sinica

Published: April 10, 2020

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.

Journal: Nature communications

Published: February 28, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026